Business / Finance

RSS

Tianyin Pharmaceutical sales decrease 26.9% to $69.6 million for fiscal year 2012

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2012.

28 Sep 2012

Lessons on the journey to commercialisation

One of the Asia Pacific region’s best known biotech leaders, Dr Greg Collier, says successful commercialisation of a new drug or therapy takes, “discipline, a strong set of nerves and a stroke of luck.”

28 Sep 2012

Physicians Endoscopy announces acquisition of minority interest in DHA

Physicians Endoscopy, LLC (PE), the leading GI ASC development and management company in the ASC industry, is pleased to announce the acquisition of a minority interest in the Digestive Health Associates Endoscopy Center, LLC (DHA) located in Stoneham, MA.

28 Sep 2012

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva Pharmaceutical Industries Ltd announced today that it has concluded an Asset Transfer Agreement with NeuroSearch A/S of Denmark to purchase all rights, assets and obligations relating to Huntexil (pridopidine / ACR16), a drug candidate being developed for the symptomatic treatment of hand movement, balance and gait disturbances in Huntington disease (HD).

28 Sep 2012

Medtronic to acquire Kanghui

Medtronic, Inc. and China Kanghui Holdings announced today that they have entered into a merger agreement whereby Medtronic will acquire Kanghui.

From Medtronic 28 Sep 2012

Prime Healthcare Services purchases Dallas Medical Center

Prime Healthcare Services announced today that it has purchased Dallas Medical Center, located in Dallas, Texas.

27 Sep 2012

GP Strategies completes acquisition of Rovsing Dynamics

Global performance improvement solutions provider GP Strategies Corporation announced that it has completed its acquisition of operating assets of Rovsing Dynamics, a provider of vibration condition monitoring hardware and software.

27 Sep 2012

Landec first quarter revenues increase 39% to $102.1 million

Landec Corporation today reported results for the first quarter of fiscal year 2013 ended August 26, 2012. Revenues increased 39% to $102.1 million compared to revenues of $73.3 million for the first quarter a year ago. Net income increased 40% to $2.5 million or $0.10 per share compared to $1.8 million or $0.07 per share for the first quarter of last year.

27 Sep 2012

Retail Benefits acquires My HSA Rewards

Retail Benefits today announced the acquisition of My HSA Rewards, an innovative program that allows employees to use cash back from shopping to reduce healthcare costs.

26 Sep 2012

Accenture acquires Octagon Research Solutions

Accenture has completed its acquisition of Octagon Research Solutions, Inc., a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry based in Wayne, Pa. The acquisition was announced on Aug. 2.

26 Sep 2012

InterCure signs strategic service agreement with private company

XTL Biopharmaceuticals Ltd. today announced that InterCure Ltd., which is approximately 45.4% (50.79% on a fully diluted basis) held by XTL, signed a strategic service agreement with a private company wholly owned by Mr. Shay Ben Yitzhak and Mr. Avner Yassur.

25 Sep 2012

SCIOinspire unveils new company name

SCIOinspire Corp., which has served the healthcare marketplace since 2008, today unveiled a new name that reflects its current core focus and corporate identity.

25 Sep 2012

Regions Hospital reports $49 million in community benefit in 2011

Regions Hospital reported $49 million in community benefit in 2011. Regions calculates community benefit by using standards set by the Catholic Health Association and used by the Internal Revenue Service for nonprofit hospitals filing Form 990.

25 Sep 2012

Electromed fiscal 2012 net revenues increase to $19.5 million

Electromed, Inc., today announced financial results for the 2012 fourth quarter and fiscal year, ended June 30, 2012.

25 Sep 2012

Health Care REIT completes public offering of 29,900,000 shares of common stock

Health Care REIT, Inc. today announced it has successfully completed its public offering of 29,900,000 shares of common stock at a price of $56.00 per share for total gross proceeds of approximately $1.7 billion. Total shares sold includes 3,900,000 shares sold pursuant to the underwriters' exercise in full of their option to purchase additional shares.

25 Sep 2012

pSivida reports revenues of $699,000 for fourth quarter 2012

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial results for its fourth quarter and fiscal year ended June 30, 2012.

25 Sep 2012

Valeant purchases QLT’s Visudyne

Valeant Pharmaceuticals International, Inc. announced today that it has acquired Visudyne, used to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration, from QLT Inc.

24 Sep 2012

Tribogenics closes $6.2M Series A financing round

Tribogenics, a producer of innovative X-ray sources, announced today that it has closed a $6.2 million Series A financing round led by Founders Fund. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.

24 Sep 2012

Bruker to purchase preclinical imaging product portfolio and related assets from Carestream

Carestream Health and Bruker have entered into an agreement for Bruker to purchase the preclinical in-vivo imaging equipment product portfolio and related assets from Carestream's Molecular Imaging business. Financial terms of the agreement are not being disclosed.

24 Sep 2012

Sagard Capital acquires IntegraMed

Sagard Capital Partners, L.P. and IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced the completion of Sagard Capital's acquisition of IntegraMed for $14.05 per share in cash, representing a total equity purchase price of approximately $169.5 million.

21 Sep 2012